Get 30% off on all global market reports with code ONLINE30 – stay updated on tariff changes, macroeconomic trends, and more!
Historical Growth of the Pulmonary Embolism Market: Insights into Expanding Industry Size
In the past few years, the pulmonary embolism market has seen a quick expansion. The market, which stands at $2.03 billion in 2024, is projected to reach $2.26 billion in 2025, showing a compound annual growth rate (CAGR) of 11.4%. This growth during the historic period is largely due to the availability of anticoagulant treatments, extensive research, and clinical trials, increase in awareness about pulmonary embolism, and vte prophylaxis.
The market size for pulmonary embolism is predicted to experience swift expansion in the upcoming years, escalating to $3.62 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 12.5%. The projected growth within this period is related to factors such as targeted therapies, telemedicine and remote patient monitoring, initiatives for health equity and global health. Key trends anticipated in this period encompass the application of artificial intelligence for diagnosis, the introduction of novel anticoagulants, the establishment of pulmonary embolism response teams, and emphasis on patient-centered care.
Claim Your Free Sample Report:
http://www.thebusinessresearchcompany.com/sample….p;type=smp
What Core Factors Are Driving the Expansion of the Pulmonary Embolism Market?
The growth of the pulmonary embolism market is anticipated to be driven by the rising instances of blood clots. Also known as a thrombus, a blood clot is a gel-like or semisolid lump formed within a blood vessel. It escalates the chances of pulmonary embolism by limiting the blood supply to the lungs. This clot can lead to blockage, typically in the legs’ deep veins, elevating the risk of pulmonary embolism.
For example, Gavi, the Vaccine Alliance, an international body that aims to amplify access to new and underutilized vaccines for children, noted in an article in April 2022 that scientists found a 33-fold rise in the possibility of lethal lung clots and a five-fold increase in deep vein thrombosis risk in the 30 days after exposure to COVID-19. Consequently, the escalating incidence of blood clots is fostering the growth of the pulmonary embolism market.
How Is the Pulmonary Embolism Market Structured Across Key Segments?
The pulmonary embolismmarket covered in this report is segmented –
1) By Treatment: Medications; Mechanical Devices; Other Treatments
2) By Diagnosis: Chest X-Ray; Electrocardiogram (ECG); Magnetic Resonance Imaging (MRI); Computed Tomography Scan; Pulmonary Angiography; Venography; Venous Ultrasound; D-Dimer Test; Other Diagnosis
3) By Symptoms: Shortness Of Breath; Chest Pain; Cough; Irregular Heartbeat; Dizziness; Fever; Cyanosis; Other Symptoms
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels
5) By End-User: Hospitals; Specialty Clinics; Homecare; Other End-Users
Subsegments:
1) By Medications: Anticoagulants; Thrombolytics
2) By Mechanical Devices: Inferior Vena Cava (IVC) Filters; Catheter-Assisted Thrombectomy
3) By Other Treatments: Surgical Embolectomy; Supportive Care
Access the Full Report Today:
http://www.thebusinessresearchcompany.com/report/…ket-report
What Innovation Trends Will Redefine the Pulmonary Embolism Market Landscape?
Prominent businesses in the pulmonary embolism market are prioritizing the creation of cutting-edge products like the Triever16 Curve catheter and the RevCore thrombectomy catheter to achieve a competitive edge. Take for example Inari Medical Inc., a medical device company from the US, which in June 2023 launched the Triever16 Curve catheter and the RevCore thrombectomy catheter. These state-of-the-art creations are highly trackable, with the Triever16 Curve catheter expressly built for peripheral thrombectomy and pulmonary embolism procedures. Complete with a pre-shaped curve for concentrated aspiration, it has a distinctive design that facilitates easy entry to the larger and more impactful 20F or 24F catheters. The RevCore thrombectomy catheter is crafted to address venous in-stent thrombosis and functions as a mechanical thrombectomy device with a nitinol basket to seize and dispose of blood clots. Besides, these catheters enhance the safety and proficiency of pulmonary embolism procedures.
Where Is the Pulmonary Embolism Market Experiencing the Fastest Regional Growth?
North America was the largest region in the pulmonary embolism market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pulmonary embolism market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Get a Customized Version of the Report:
http://www.thebusinessresearchcompany.com/customi…p;type=smp
Leading Players Shaping the Future of the Pulmonary Embolism Industry
Major companies operating in the pulmonary embolism market are Pfizer Inc., Johnson and Johnson Private Limited, F. Hoffmann-La Roche Ltd., Merck And Co.Inc., Novartis AG, Bayer AG, Sanofi S.A., Bristol Myers Squibb Company, GSK PLC, Abbott Laboratories, AstraZeneca PLC, Medtronic PLC, Eli Lilly and Company, Gilead Sciences Inc., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Daiichi Sankyo Co. Ltd., Boehringer Ingelheim International GmbH, Mitsubishi Tanabe Pharma Corporation, Genentech Inc., Hikma Pharmaceuticals PLC, Aspen Pharmacare Holdings Limited, Nippon Shinyaku Co. Ltd., Penumbra Inc., Fresenius Kabi AG, Inari Medical Inc., AngioDynamics Inc., Otsuka Pharmaceutical Co. Ltd.
Access the Complete Report:
http://www.thebusinessresearchcompany.com/purchas…x?id=13026
How Our Market Research Reports Help Maximize ROI Across Industries:
* Identify High-Growth Opportunities: Pinpoint emerging trends, untapped segments, and regional hotspots that align with your strategic goals.
* Reduce Investment Risk: Make data-driven decisions with confidence by understanding market dynamics, key drivers, and competitive threats.
* Optimize Strategic Planning: Align your product development, marketing, and expansion plans with industry forecasts and customer behaviour insights.
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
News From
The Business Research Company …
Category: Industry Reports & Market Analysis Profile: The Business Research Company is a leading market research and consulting services provider. It offers over 9,500 market reports across 27 industries in 60+ geographies, providing detailed insights and forecasts. Its customised research solutions support companies in making critical decisions, while its continuous research service enhances organizational capabilities. The flagship Global Market Model database provides comprehensive market intelligence with 1,500,000 datasets covering 8,000+ mark …
This email address is being protected from spambots. You need JavaScript enabled to view it.
